Italian study tracks Real-World use of new cholesterol drug inclisiran
NCT ID NCT06287177
First seen Jan 22, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study will follow 3,000 Italian adults taking Inclisiran, a long-acting cholesterol-lowering injection, to see how consistently they take it and how much their LDL (bad) cholesterol drops. Researchers want to understand real-world adherence and effectiveness, not test a new treatment. Participants must be between 18 and 80 years old and already prescribed Inclisiran.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Federico II University of Naples, Department of Advanced Biomedical Sciences
RECRUITINGNaples, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.